Mindbloom Overview
Pro stress-test →Mindbloom is an American telemedicine company that treats anxiety and depression via ketamine-assisted therapy. The company is one of the largest providers of guided at-home ketamine therapy in the United States. Mindbloom has facilitated over 700,000 clinician-supervised sessions to date.
Strategic Profile
Pro stress-test →The company delivers clinician-supervised sublingual and subcutaneous ketamine as part of a comprehensive therapeutic program, rather than operating as a prescription-only service. Mindbloom's integration framework (journaling prompts, recorded playlists, guided sessions) is the most polished in the industry. In a peer-reviewed study of 11,441 Mindbloom clients, 89% of participants reported improvement in their symptoms, with 56.4% meeting criteria for depression response and 56.1% meeting criteria for anxiety response.
Competitive Landscape
Pro stress-test →Mindbloom is the most visible at-home ketamine brand. Key competitors include Joyous (daily microdosing subscription model at $129/month) and Nue Life. Mindbloom utilizes a defined treatment framework with periodic therapeutic doses, while Joyous employs a daily microdosing subscription model. Mindbloom has published two peer-reviewed studies evaluating its specific clinical protocol, while Joyous offers a daily dosing model for which peer-reviewed outcomes research has not yet been published.
Industry Context
Mindbloom operates in At-home ketamine-assisted psychedelic therapy.
Key facts
Founded: 2018 · Headquarters: Unknown, US